This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stacy London Launches Uncover Your Confidence™ Campaign To Empower People Living With Psoriasis

NORTH CHICAGO, Ill., July 8, 2013 /PRNewswire/ -- Stacy London, style expert and co-host of TLC's "What Not to Wear," today announced her partnership with AbbVie (NYSE: ABBV) on a new psoriasis campaign called Uncover Your Confidence. The campaign features educational resources and style advice for the estimated 7.5 million American men and women living with psoriasis.[1] Commonly mistaken as "just a skin condition," psoriasis is actually a chronic disease of the immune system that appears on the skin.

To view the multimedia assets associated with this release, please click:

Stacy has lived with psoriasis since the age of 4 and has a deep understanding of the disease and the personal effect it can have. "Through the Uncover Your Confidence campaign, I hope to inspire others living with psoriasis to be self-assured through their own personal style, stay positive and find the right dermatologist to help them manage their disease," said London. "Empowering people to feel more confident in their skin is what I always strive to do and psoriasis is a cause that is particularly near and dear to me."

"It's incredibly powerful to hear Stacy speak about her personal experience with psoriasis," said Maria Rivas, M.D., Vice President, Global Medical Affairs, AbbVie. "Through this partnership, we aim to educate, provide resources and tools, and bring Stacy's style expertise to people living with this chronic condition so that they can confidently confront their disease each and every day."

Providing psoriasis-friendly style advice and educational resources for both men and women, features:
  • Stacy's Guide to Style, complete with seasonal style tips for home and wardrobe for people living with psoriasis
  • Videos with Stacy answering common questions of interest for people with psoriasis
  • Video series featuring Stacy's personal psoriasis journey and stories from other individuals living with psoriasis
  • An online search tool to find a local dermatologist who manages psoriasis
  • Access to the Psoriasis Patient Advocate Program which pairs those with psoriasis with trained professionals in their local area who can provide one-to-one support, education, and resources. The Psoriasis Patient Advocate Program is not a replacement for a medical professional or a dermatologist trained in treating psoriasis. The Patient Advocates will not provide medical advice.

Learn more at

Mu l timedia news release To view multimedia assets associated with this release, please click here: 

A bou t PsoriasisPsoriasis is a chronic immune disease that appears on the skin. It affects an estimated 125 million people worldwide. It is a non-contagious disorder that speeds the growth cycle of skin cells and results in thick, scaly areas of skin. The most common form, called plaque psoriasis, appears as red, raised areas of skin covered with flaky white scales, which are often itchy and can crack and bleed. Currently, there is no cure but treatment can help control the condition. Treatment may include topical agents, phototherapy or systemic medications taken orally or by injection or infusion. More information can be found at

A bou t AbbVieAbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

[1] About Psoriasis: Statistics. National Psoriasis Foundation website. Accessed May 3, 2013. This campaign is not affiliated with, endorsed by or funded by the National Psoriasis Foundation.


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs